MarcB.GarnickMD

PubMed

• Reply: Cardiovascular Risk in Prostate Cancer Patients Using Luteinizing Hormone-Releasing Hormone Agonists or a Gonadotropin-Releasing Hormone Antagonist.
  Hafron, J., Crawford, E., Garnick, M.> ;The Journal of Urology. 2024 Mar 1
• Editorial Comment.
  Garnick, M., Crawford, E.> ;Urology Practice. 2024 Jan 1
• Reply by Authors.
  Hafron, J. M., E David Crawford, Marc B Garnick, Robert H Eckel, Martin M Miner, Stephen J Freedland, Russell K Pachynski, Richard J Wassersug, Matthew T Rosenberg, La...> ;Urology Practice. 2024 Jan 1
• A Proposal for the Comprehensive Care of Men on Androgen Deprivation Therapy: Recommendations From the Multidisciplinary Prostate Cancer 360 Working Group.
  E David Crawford, Marc B Garnick, Robert H Eckel, Martin M Miner, Stephen J Freedland, Russell K Pachynski, Richard J Wassersug, Matthew T Rosenberg, Lauren M Walker, ...> ;Urology Practice. 2024 Jan 1
• 2 citations
  Cardiovascular Risk in Prostate Cancer Patients Using Luteinizing Hormone-Releasing Hormone Agonists or a Gonadotropin-Releasing Hormone Antagonist.
  E David Crawford, Jason M Hafron, Frans Debruyne, Christopher Wallis, Steven Chang, Marc B Garnick> ;The Journal of Urology. 2024 Jan 1
• EDITORIAL COMMENT.
  Marc B Garnick, Andrew A Wagner> ;Urology. 2022 Jul 1
• EDITORIAL COMMENT.
  Marc B Garnick, Aria Olumi> ;Urology. 2021 Sep 1
• EDITORIAL COMMENT.
  Marc B Garnick, David J Einstein> ;Urology. 2020 Nov 1
• 3 citations
  Evolving understanding and categorization of prostate cancer: preventing progression to metastatic castration-resistant prostate cancer: RADAR IV.
  E. David Crawford, Gerald L. Andriole, Stephen J. Freedland, Marc B. Garnick, Leonard G. Gomella, Jonathan Henderson, Celestia Tia Higano, Andrew Karim Kader, Christop...> ;The Canadian Journal of Urology. 2020 Oct 1
• 135 citations
  Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019
  Veda N. Giri, Karen E. Knudsen, William Kevin Kelly, Heather H. Cheng, Kathleen A. Cooney, Michael S. Cookson, William L. Dahut, Scott Weissman, Howard R. Soule, Danie...> ;Journal of Clinical Oncology. 2020 Aug 20
• 1 citations
  EDITORIAL COMMENT.
  Marc B Garnick, David J Einstein> ;Urology. 2019 Sep 1
• More on Long-Term Effects of Finasteride on Prostate Cancer Mortality.
  Garnick, M. B.> ;The New England journal of medicine. 2019 May 16
• 3 citations
  Filling in the Gaps.
  Marc B. Garnick> ;JAMA. 2018 May 22
• 59 citations
  The potential role of follicle-stimulating hormone in the cardiovascular, metabolic, skeletal, and cognitive effects associated with androgen deprivation therapy.
  E. David Crawford, Andrew V. Schally, Jehonathan H. Pinthus, Norman L. Block, Ferenc G. Rick, Marc B. Garnick, Robert H. Eckel, Thomas E. Keane, Neal D. Shore, David N...> ;Urologic Oncology. 2017 May 1
• Rethinking the use of physicians as hired expert lecturers.
  Marc B. Garnick, Wendy Balter> ;Annals of Internal Medicine. 2015 Feb 17
• 27 citations
  Testosterone Replacement Therapy Faces FDA Scrutiny
  Marc B. Garnick> ;JAMA. 2015 Feb 10
• Reply to S. Barni et Al and M. Sun et Al.
  Marc B. Garnick> ;Journal of Clinical Oncology. 2014 Nov 20
• 7 citations
  How to Interpret Patient Preferences in Selecting the Best Drug: Are the Current Measurements up to the Job?
  Marc B. Garnick> ;Journal of Clinical Oncology. 2014 May 10
• 8 citations
  Preserving the Sanctity of Overall Survival for Drugs Approved on the Basis of Progression-Free Survival: Tivozanib As a Case Study
  Marc B. Garnick> ;Journal of Clinical Oncology. 2013 Oct 20
• 41 citations
  The utility of prostate-specific antigen in the management of advanced prostate cancer
  E. David Crawford, Gerald L. Andriole, Marc B. Garnick, Daniel P. Petrylak> ;BJU International. 2013 Sep 1
• 1 citations
  More on confusion of drug names.
  Marc B. Garnick> ;The New England Journal of Medicine. 2013 May 16
• 4 citations
  Possible confusion in names of new treatments for prostate cancer.
  Marc B. Garnick> ;The New England Journal of Medicine. 2013 Jan 9
• 2 citations
  Editorial comment. Prostate-specific antigen response to deferred combined androgen blockade therapy using bicalutamide predicts survival after subsequent oestrogen an...
  Marc B. Garnick> ;BJU International. 2012 Oct 1
• Recommendations on use of prostate-specific antigen for prostate cancer screening.
  Marc B. Garnick> ;JAMA. 2012 Apr 4
• Ask the doctor. I take Avodart for my enlarged prostate. But I heard that Avodart increases prostate cancer risk. Is that true? Should I quit taking Avodart?
  Marc B. Garnick> ;Harvard Health Letter. 2012 Jan 1
• Join now to see all